Reference health

Cancer Treatment-Related Infertility: A Critical Review of the Evidence

https://doi.org/10.1093/jncics/pkz008
CiteStamped reference-health badge
193/193 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

13 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 193 checked references that resolve
resolves10.1007/s13187-016-0997-2
Who Is a Cancer Survivor? A Systematic Review of Published Definitions
resolves10.1016/j.fertnstert.2018.05.034
RETIRED: Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion
resolves10.1002/cncr.26459
Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer
resolves10.1056/NEJMra0801454
Preservation of Fertility in Patients with Cancer
resolves10.1007/s11864-012-0183-7
Pediatric and Young Adult Patients and Oncofertility
resolves10.1186/s12916-015-0545-7
Cancer and fertility preservation: international recommendations from an expert meeting
resolves10.1016/S2213-8587(15)00039-X
Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults
resolves10.1002/cncr.30047
Fertility preservation in children, adolescents, and young adults with cancer: Quality of clinical practice guidelines and variations in recommendations
resolves10.1093/annonc/mdt199
Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
resolves10.1016/j.fertnstert.2013.08.012
Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion
resolves10.1093/humrep/des472
Genetic variation may modify ovarian reserve in female childhood cancer survivors
resolves10.1016/j.fertnstert.2009.03.034
Association of cyclophosphamide drug–metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors
resolves10.1186/s12885-016-2373-3
SLCO1B1*5 polymorphism (rs4149056) is associated with chemotherapy-induced amenorrhea in premenopausal women with breast cancer: a prospective cohort study
resolves10.1200/JCO.2011.40.8906
Parenthood in Survivors of Hodgkin Lymphoma: An EORTC-GELA General Population Case-Control Study
resolves10.1002/cncr.26403
Acute ovarian failure underestimates age‐specific reproductive impairment for young women undergoing chemotherapy for cancer
resolves10.1016/j.fertnstert.2015.11.020
Menses resumption after cancer treatment–induced amenorrhea occurs early or not at all
resolves10.1016/j.fertnstert.2009.03.045
Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer
resolves10.1016/j.fertnstert.2011.10.040
Impact of cancer therapies on ovarian reserve
resolves10.1210/jc.2003-030352
Reduced Ovarian Function in Long-Term Survivors of Radiation- and Chemotherapy-Treated Childhood Cancer
resolves10.1093/humrep/deg042
Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3
resolves10.1210/en.2005-1588
Serum Anti-Müllerian Hormone Levels Reflect the Size of the Primordial Follicle Pool in Mice
resolves10.1093/humupd/dmt062
The physiology and clinical utility of anti-Müllerian hormone in women
resolves10.1093/humrep/deg473
Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound
resolves10.1016/j.rbmo.2009.11.010
Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results
resolves10.1016/j.fertnstert.2013.08.052
Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors
resolves10.1200/JCO.2008.20.1541
Fertility of Female Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
resolves10.1016/S1470-2045(13)70251-1
Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort
resolves10.1093/jnci/djj243
Premature Menopause in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
resolves10.1016/S1470-2045(16)00086-3
Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort
resolves10.1093/humrep/dev060
Ovarian reserve after treatment with alkylating agents during childhood
resolves10.1016/j.rbmo.2014.10.010
The effect of childhood cancer therapy on ovarian reserve and pubertal development
resolves10.1093/humrep/des391
Age at menopause and its influencing factors in a cohort of survivors of childhood cancer: earlier but rarely premature
resolves10.1093/oxfordjournals.aje.a009995
Early Menopause and Infertility in Females after Treatment for Childhood Cancer Diagnosed in 1964-1988 in Ontario, Canada
resolves10.1056/NEJM198711193172104
Effects of Treatment on Fertility in Long-Term Survivors of Childhood or Adolescent Cancer
resolves10.1200/JCO.2015.64.3288
Recommendations for Premature Ovarian Insufficiency Surveillance for Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Report From the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration With the PanCareSurFup Consortium
resolves10.1016/j.fertnstert.2012.04.021
Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma—evaluation by using antimüllerian hormone and retrieved oocytes
resolves10.1016/S1470-2045(15)70140-3
Parenthood in adult female survivors treated for Hodgkin's lymphoma during childhood and adolescence: a prospective, longitudinal study
resolves10.1200/JCO.2018.78.0858
Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient–Level Data
resolves10.1200/JCO.2005.03.3969
Incidence, Time Course, and Determinants of Menstrual Bleeding After Breast Cancer Treatment: A Prospective Study
resolves10.1002/cncr.25106
Incidence and time course of bleeding after long‐term amenorrhea after breast cancer treatment
resolves10.1002/cncr.21385
Incidence of chemotherapy‐induced, long‐term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane
resolves10.1007/s10549-008-0071-9
Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer
resolves10.1089/jwh.1.1999.8.949
The Risk of Premature Menopause Induced by Chemotherapy for Early Breast Cancer
resolves10.1007/s12282-011-0256-7
Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane
resolves10.1007/s00280-013-2227-5
Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study
resolves10.1002/cncr.24835
The effects of paclitaxel, dose density, and trastuzumab on treatment‐related amenorrhea in premenopausal women with breast cancer
resolves10.1200/JCO.2010.29.7689
Menstrual History and Quality-of-Life Outcomes in Women With Node-Positive Breast Cancer Treated With Adjuvant Therapy on the NSABP B-30 Trial
resolves10.1007/s10549-015-3426-z
Chemotherapy-related amenorrhea after adjuvant paclitaxel–trastuzumab (APT trial)
resolves10.1200/jco.2015.33.15_suppl.9523
Treatment-related amenorrhea among young women one year following diagnosis of early-stage breast cancer.
resolves10.1097/gme.0b013e3181f3e6e7
Taxane-based regimens as a risk factor for chemotherapy-induced amenorrhea
resolves10.1097/01.coc.0000251398.57630.4f
The Rates of Chemotherapy-Induced Amenorrhea in Patients Treated With Adjuvant Doxorubicin and Cyclophosphamide Followed by a Taxane
resolves10.1097/CAD.0b013e3283243df3
Determinants of recovery from amenorrhea in premenopausal breast cancer patients receiving adjuvant chemotherapy in the taxane era
resolves10.1016/j.fertnstert.2007.09.048
Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers
resolves10.1016/j.ejca.2016.10.030
Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies
resolves10.1093/humupd/7.6.535
The effects of radiotherapy and chemotherapy on female reproduction
resolves10.1006/gyno.1994.1221
Menstrual and Hormone Patterns in Women Treated with High-Dose Cisplatin and Bleomycin
resolves10.1002/1097-0142(20000715)89:2<391::AID-CNCR26>3.0.CO;2-V
Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors
resolves10.1200/JCO.1999.17.8.2365
Risk of Menopause During the First Year After Breast Cancer Diagnosis
resolves10.1056/NEJMoa0909638
Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer
resolves10.1056/NEJMoa1412379
Adjuvant Ovarian Suppression in Premenopausal Breast Cancer
resolves10.1056/NEJMoa1803164
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
resolves10.1016/S0015-0282(01)01895-7
Successful in vitro fertilization–surrogate pregnancy in a patient with ovarian transposition who had undergone chemotherapy and pelvic irradiation
resolves10.1016/j.fertnstert.2005.01.093
In vitro fertilization surrogate pregnancy in a patient who underwent radical hysterectomy followed by ovarian transposition, lower abdominal wall radiotherapy, and chemotherapy
resolves10.1016/j.ygyno.2016.01.028
Reproductive and oncologic outcome following robot-assisted laparoscopic radical trachelectomy for early stage cervical cancer
resolves10.1111/j.1471-0528.2006.00936.x
Radical vaginal trachelectomy as a fertility‐sparing procedure in women with early‐stage cervical cancer—cumulative pregnancy rate in a series of 123 women
resolves10.1097/IGC.0000000000000571
Pregnancy Outcomes After Abdominal Radical Trachelectomy for Early-Stage Cervical Cancer
resolves10.1016/j.ygyno.2010.12.345
The vaginal radical trachelectomy: An update of a series of 125 cases and 106 pregnancies
resolves10.1016/j.ygyno.2012.03.014
Reproductive outcomes of patients undergoing radical trachelectomy for early-stage cervical cancer
resolves10.1016/j.ygyno.2013.06.010
Surgical, oncological, and obstetrical outcomes after abdominal radical trachelectomy — A systematic literature review
resolves10.1097/IGC.0b013e3182230294
Fertility Outcome After Radical Vaginal Trachelectomy
resolves10.1007/s10147-014-0763-6
Outcomes of abdominal radical trachelectomy: results of a multicenter prospective cohort study in a Tohoku Gynecologic Cancer Unit
resolves10.1097/IGC.0b013e318263eee2
An International Series on Abdominal Radical Trachelectomy
resolves10.1007/s10147-016-1059-9
Oncologic and obstetric outcomes and complications during pregnancy after fertility-sparing abdominal trachelectomy for cervical cancer: a retrospective review
resolves10.1016/j.fertnstert.2016.06.032
Fertility results and pregnancy outcomes after conservative treatment of cervical cancer: a systematic review of the literature
resolves10.1016/j.ygyno.2014.08.021
Oncological and pregnancy outcomes after high-dose density neoadjuvant chemotherapy and fertility-sparing surgery in cervical cancer
resolves10.1016/j.ygyno.2006.12.001
A new approach for laparoscopic ovarian transposition before pelvic irradiation
resolves10.1097/AOG.0b013e31827a0643
Pregnancy Outcomes After Fertility-Sparing Management in Young Women With Early Endometrial Cancer
resolves10.1111/IGC.0b013e3181aae1fb
Conservative Treatment With Progestin and Pregnancy Outcomes in Endometrial Cancer
resolves10.1200/JCO.2009.24.8617
Outcomes of Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer: A Proposal for Patient Selection
resolves10.3802/jgo.2014.25.4.320
Fertility sparing surgery in early stage epithelial ovarian cancer
resolves10.1631/jzus.B1100166
Clinical outcomes of fertility-sparing treatments in young patients with epithelial ovarian carcinoma
resolves10.1016/j.ajog.2011.01.025
Fertility preserving options in patients with gynecologic malignancies
resolves10.1136/pmj.78.916.92
Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer
resolves10.1210/jcem.86.8.7719
<sup>131</sup>I Therapy for Differentiated Thyroid Cancer Leads to an Earlier Onset of Menopause: Results of a Retrospective Study
resolves10.1111/j.1365-2265.2008.03222.x
A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors
resolves10.6004/jnccn.2010.0094
Complications of Radioactive Iodine Treatment of Thyroid Carcinoma
resolves10.1002/ijc.30917
Birth rates after radioactive iodine treatment for differentiated thyroid cancer
resolves10.1200/JCO.2005.08.138
Secondary Amenorrhea After Hodgkin’s Lymphoma Is Influenced by Age at Treatment, Stage of Disease, Chemotherapy Regimen, and the Use of Oral Contraceptives During Therapy: A Report From the German Hodgkin’s Lymphoma Study Group
resolves10.1182/blood-2007-05-090225
Treatment-related risk factors for premature menopause following Hodgkin lymphoma
resolves10.1200/JCO.2012.44.3721
Gonadal Function and Fertility in Survivors After Hodgkin Lymphoma Treatment Within the German Hodgkin Study Group HD13 to HD15 Trials
resolves10.1007/s10815-015-0636-6
Fertility in young patients following treatment for Hodgkin’s lymphoma: a single center survey
resolves10.1200/JCO.2011.37.1989
Premature Ovarian Failure and Fertility in Long-Term Survivors of Hodgkin's Lymphoma: A European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Étude des Lymphomes de l'Adulte Cohort Study
resolves10.1002/hon.802
Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy
resolves10.1093/humrep/dei018
Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma
resolves10.1080/10428190500353877
Fertility status among women treated for aggressive non-Hodgkin's lymphoma
resolves10.1182/blood-2010-07-295444
Pregnancy outcomes after maternal exposure to rituximab
resolves10.1182/blood.V108.11.3315.3315
Chemotherapy-Related Amenorrhea (CRA) among Premenopausal Patients Treated for Acute Leukemia.
resolves10.1002/(SICI)1097-0142(19991001)86:7<1231::AID-CNCR18>3.0.CO;2-Y
Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone
resolves10.1200/JCO.1997.15.11.3347
Successful pregnancy after allogeneic bone marrow transplant with embryos isolated before transplant.
resolves10.1200/JCO.2005.04.6557
Pregnancy Among Patients With Chronic Myeloid Leukemia Treated With Imatinib
resolves10.1182/blood-2007-10-114900
The effects of imatinib on pregnancy outcome
resolves10.4084/mjhid.2014.028
TYROSINE KINASE INHIBITORS AND PREGNANCY
resolves10.1634/theoncologist.2011-0137
Will Imatinib Compromise Reproductive Capacity?
resolves10.1056/NEJMc0707841
Primary Ovarian Insufficiency Associated with Imatinib Therapy
resolves10.1016/S1470-2045(10)70233-3
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
resolves10.1016/j.bbmt.2010.07.009
Pregnancy after Hematopoietic Cell Transplantation: A Report from the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research (CIBMTR)
resolves10.1016/S0140-6736(01)05482-4
Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey
resolves10.1038/sj.bmt.1705364
Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the bone marrow transplant survivor study
resolves10.1038/bmt.2013.211
Clinical guide to fertility preservation in hematopoietic cell transplant recipients
resolves10.1182/blood.V87.7.3045.bloodjournal8773045
Pregnancies following high-dose cyclophosphamide with or without high- dose busulfan or total-body irradiation and bone marrow transplantation
resolves10.1200/JCO.2007.10.8993
Fertility and Risk Factors for Elevated Infertility Concern in 10-Year Hematopoietic Cell Transplant Survivors and Case-Matched Controls
resolves10.1038/bmt.2015.178
Prevalence of menstrual cycles and outcome of 50 pregnancies after high-dose chemotherapy and auto-SCT in non-Hodgkin and Hodgkin lymphoma patients younger than 40 years
resolves10.1111/ejh.12737
Fertility in premenopausal women post autologous stem cell transplant with <scp>BEAM</scp> conditioning
resolves10.1200/JCO.1988.6.5.813
Ovarian function following marrow transplantation for aplastic anemia or leukemia.
resolves10.1093/humrep/deg016
The radiosensitivity of the human oocyte
resolves10.1016/S1470-2045(05)70092-9
Fertility preservation for young patients with cancer: who is at risk and what can be offered?
resolves10.1210/jc.2006-0020
Acute Ovarian Failure in the Childhood Cancer Survivor Study
resolves10.1093/oxfordjournals.humrep.a137570
Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause
resolves10.1016/j.clcc.2014.09.012
Incidence of Chemotherapy- and Chemoradiotherapy-Induced Amenorrhea in Premenopausal Women With Stage II/III Colorectal Cancer
resolves10.1016/j.ijrobp.2009.04.012
Fertility and Pregnancy Outcome After Abdominal Irradiation That Included or Excluded the Pelvis in Childhood Tumor Survivors
resolves10.1155/2014/482968
The Impact of Uterine Radiation on Subsequent Fertility and Pregnancy Outcomes
resolves10.1111/j.1471-0528.1992.tb13755.x
Abdominal irradiation in childhood; the potential for pregnancy
resolves10.1111/j.1600-0412.2004.00332.x
Radiotherapy at a young age reduces uterine volume of childhood cancer survivors
resolves10.1016/j.ijrobp.2008.12.016
Impact of Radiotherapy on Fertility, Pregnancy, and Neonatal Outcomes in Female Cancer Patients
resolves10.1002/mpo.2950190603
Reproduction following treatment for childhood leukemia: A population‐based prospective cohort study of fertility and offspring
resolves10.1002/pbc.20033
Fertility in women treated with cranial radiotherapy for childhood acute lymphoblastic leukemia
resolves10.1016/j.fertnstert.2011.02.002
Decreased fertility among female childhood cancer survivors who received 22–27 Gy hypothalamic/pituitary irradiation: a report from the Childhood Cancer Survivor Study
resolves10.1016/S0360-3016(00)01387-0
Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose–effect relationship using dose–volume histogram analysis
resolves10.1016/j.fertnstert.2014.10.021
Limitations of semen analysis as a test of male fertility and anticipated needs from newer tests
resolves10.1016/S0140-6736(97)10514-1
Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners
resolves10.1093/humrep/17.2.503
Time to pregnancy and semen parameters: a cross-sectional study among fertile couples from four European cities
resolves10.1002/j.1939-4640.2000.tb03284.x
Semen Quality and Human Fertility: A Prospective Study With Healthy Couples
resolves10.1016/j.fertnstert.2013.10.022
Semen quality and time to pregnancy: the Longitudinal Investigation of Fertility and the Environment Study
resolves10.1007/s10815-012-9921-9
Balanced chromosomal translocations in men: relationships among semen parameters, chromatin integrity, sperm meiotic segregation and aneuploidy
resolves10.1016/S0015-0282(97)81465-3
Fertility after chemotherapy for testicular germ cell cancer
resolves10.1111/j.1464-410X.1989.tb05292.x
Is Routine Pre‐treatment Cryopreservation of Semen Worthwhile in the Management of Patients with Testicular Cancer?
resolves10.1111/j.1464-410X.1988.tb04272.x
Seminal Analysis after Orchiectomy in Stage I Teratoma
resolves10.1016/S0015-0282(16)47605-3
Sperm counts and serum follicle-stimulating hormone levels before and after radiotherapy and chemotherapy in men with testicular germ cell cancer
resolves10.1023/A:1012464703805
Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment
resolves10.3324/haematol.2009.009696
Sperm quality before treatment in patients with early stage Hodgkin's lymphoma enrolled in EORTC-GELA Lymphoma Group trials
resolves10.1016/0277-5379(91)90017-8
Testicular dysfunction in Hodgkin's disease before and after treatment
resolves10.1111/j.1464-410X.1983.tb03423.x
Semen Analysis in Testicular Cancer and Hodgkin's Disease: Pre‐ and Post‐Treatment Findings and Implications for Cryopreservation
resolves10.1016/j.fertnstert.2014.06.008
Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network
resolves10.1016/S0015-0282(16)53768-6
Recovery of impaired pretreatment spermatogenesis in testicular cancer
resolves10.1097/00005392-200101000-00023
SPERMATOGENESIS AFTER UNILATERAL ORCHIECTOMY FOR TESTICULAR CANCER IN PATIENTS FOLLOWING SURVEILLANCE POLICY
resolves10.1182/blood-2002-07-2231
Nonmalignant late effects after allogeneic stem cell transplantation
resolves10.1016/j.fertnstert.2013.08.010
Effects of chemotherapy and radiotherapy on spermatogenesis in humans
resolves10.1002/1097-0142(19921201)70:11<2703::AID-CNCR2820701123>3.0.CO;2-X
Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for ewing and soft tissue sarcomas
resolves10.1200/JCO.2010.33.7808
Successful Treatment of Postchemotherapy Azoospermia With Microsurgical Testicular Sperm Extraction: The Weill Cornell Experience
resolves10.1007/s10147-016-0998-5
Microdissection testicular sperm extraction in Japanese patients with persistent azoospermia after chemotherapy
resolves10.1016/S1470-2045(14)70408-5
Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study
resolves10.1007/s11764-014-0354-6
Male infertility in long-term survivors of pediatric cancer: a report from the childhood cancer survivor study
resolves10.1200/JCO.2009.24.9037
Fertility of Male Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
resolves10.1002/pbc.24679
The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: A report from the childhood cancer survivor study
resolves10.1002/pbc.10449
Fertility of long‐term male survivors of acute lymphoblastic leukemia diagnosed during childhood
resolves10.1001/jama.1988.03720140043031
The Relationship of Gonadal Activity and Chemotherapy-Induced Gonadal Damage
resolves10.1016/S0022-5347(01)61781-6
SEMEN QUALITY AND REPRODUCTIVE HORMONES BEFORE AND AFTER ORCHIECTOMY IN MEN WITH TESTICULAR CANCER
resolves10.1002/cncr.10804
Bilateral testicular germ cell tumors
resolves10.1111/j.1464-410X.1985.tb06425.x
Post‐treatment Fertility in Patients with Testicular Cancer: I. Influence of Retroperitoneal Lymph Node Dissection on Ejaculatory Potency
resolves10.3109/01485018708988491
Sexual Function After Bilateral Retroperitoneal Lymph Node Dissection for Nonseminomatous Testicular Cancer
resolves10.1016/S0090-4295(03)00324-8
Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: a long-term update
resolves10.1007/s00345-008-0299-3
Complications of laparoscopic retroperitoneal lymph node dissection in testicular cancer
resolves10.1016/j.urology.2006.10.020
Postchemotherapy Laparoscopic Retroperitoneal Lymph Node Dissection: Evaluation of Complications
resolves10.1007/s11764-010-0134-x
Fertility among testicular cancer survivors: a case-control study in the U.S.
resolves10.1093/jnci/dji339
Paternity Following Treatment for Testicular Cancer
resolves10.1016/j.eururo.2010.03.041
Paternity and Testicular Function Among Testicular Cancer Survivors Treated With Two to Four Cycles of Cisplatin-Based Chemotherapy
resolves10.1016/j.fertnstert.2013.05.018
Impact of chemotherapy and radiotherapy for testicular germ cell tumors on spermatogenesis and sperm DNA: a multicenter prospective study from the CECOS network
resolves10.1097/MOU.0b013e32831367b3
Radioactive iodine (131I) effects on male fertility
resolves10.1097/00000421-199708000-00006
Gonadal Function Following ABVD Therapy for Hodgkin's Disease
resolves10.1182/blood-2007-02-073544
Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG)
resolves10.1200/JCO.1993.11.2.239
Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas.
resolves10.1093/humrep/deh671
Semen quality before and after gonadotoxic treatment
resolves10.1002/(SICI)1097-0142(19991115)86:10<2184::AID-CNCR43>3.0.CO;2-9
Cryopreservation of sperm from patients with leukemia
resolves10.1007/s11845-014-1084-5
Pregnancy outcome in chronic myeloid leukemia patients on imatinib therapy
resolves10.1038/sj.bmt.1701332
Recovery of spermatogenesis following bone marrow transplantation
resolves10.1038/sj.bmt.1703651
Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counselling
resolves10.1182/blood-2006-01-0176
Spermatogenesis in long-term survivors after allogeneic hematopoietic stem cell transplantation is associated with age, time interval since transplantation, and apparently absence of chronic GvHD
resolves10.1182/blood-2006-08-044289
Recovery of spermatogenesis after total-body irradiation
resolves10.1038/sj.bmt.1701342
Patterns of gonadal dysfunction following bone marrow transplantation
resolves10.1038/sj.bmt.1702695
Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg)
resolves10.1016/j.ijrobp.2004.11.038
Predicting age of ovarian failure after radiation to a field that includes the ovaries
resolves10.2307/3574084
Effect of Graded Doses of Ionizing Radiation on the Human Testis
resolves10.1016/S0360-3016(96)00597-4
External beam abdominal radiotherapy in patients with seminoma stage I: Field type, testicular dose, and spermatogenesis
resolves10.4103/0971-6203.44477
Testicular shield for para-aortic radiotherapy and estimation of gonad doses
resolves10.1200/JCO.1989.7.6.718
Long-term follow-up of testicular function following radiation therapy for early-stage Hodgkin's disease.
resolves10.1002/j.1939-4640.1994.tb00507.x
Effect of Low‐Dose Testicular Irradiation on Sperm Count and Fertility in Patients with Testicular Seminoma
resolves10.1016/j.fertnstert.2011.07.1147
Semen quality and fertility in adult long-term survivors of childhood acute lymphoblastic leukemia
resolves10.1200/JCO.2015.62.4544
Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group Study AALL0232
resolves10.1093/humrep/dex082
Effect of cranial irradiation on sperm concentration of adult survivors of childhood acute lymphoblastic leukemia: a report from the St. Jude Lifetime Cohort Study†
resolves10.1016/j.ygyno.2005.03.010
Fertility and recurrence results of conservative surgery for borderline ovarian tumors
resolves10.1200/JCO.2001.19.4.1015
Survival and Reproductive Function After Treatment of Malignant Germ Cell Ovarian Tumors
resolves10.1016/j.fertnstert.2004.10.009
Fertility after conservative treatment for borderline ovarian tumors: A French multicenter study
resolves10.1111/j.1471-0528.1997.tb12062.x
Conservative surgery for Stage I ovarian carcinoma in women of childbearing age
The 13 references without a DOI — listed, not checked
no DOI — not checkedProspectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women
no DOI — not checkedChemotherapy-induced amenorrhea (CIA) risk associated with taxane/platinum-based chemotherapy in young (≤45 years) breast cancer patients
no DOI — not checkedSuccessful surrogate pregnancy after ovarian transposition, pelvic irradiation, and hysterectomy
no DOI — not checked2019070511234783400_pkz008-B67
no DOI — not checked2019070511234783400_pkz008-B81
no DOI — not checked2019070511234783400_pkz008-B84
no DOI — not checkedAssessment of female fertility and carcinogenesis after Iodine-131 therapy for differentiated thyroid carcinoma
no DOI — not checked2019070511234783400_pkz008-B95
no DOI — not checkedEffect of radiation on the human reproductive system
no DOI — not checkedWorld Health Organization Laboratory Manual for the Examination and Processing of Human Semen
no DOI — not checkedFertility after chemotherapy for testicular germ cell cancer
no DOI — not checkedPrinciples and Practice of Therapy, First edition
no DOI — not checkedKinetics of the germinal epithelium in man
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1093/jncics/pkz008"><img src="https://citestamp.com/citestamped/10.1093/jncics/pkz008/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1093/jncics/pkz008/badge.svg)](https://citestamp.com/citestamped/10.1093/jncics/pkz008)